Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
New Nordic Healthbrands AB's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -46.95%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for New Nordic Healthbrands AB's 3-Year ROIIC % or its related term are showing as below:
FRA:N9X's 3-Year ROIIC % is ranked worse than 86.52% of 1833
companies
in the Consumer Packaged Goods industry
Industry Median: 2.72
vs FRA:N9X: -46.95
New Nordic Healthbrands AB (FRA:N9X) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
New Nordic Healthbrands AB 3-Year ROIIC % Related Terms
New Nordic Healthbrands AB 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:N9X vs KHC, GIS, HRL: 3-Year ROIIC % Comparison
For the Packaged Foods subindustry, New Nordic Healthbrands AB's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
New Nordic Healthbrands AB 3-Year ROIIC % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, New Nordic Healthbrands AB's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where New Nordic Healthbrands AB's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
New Nordic Healthbrands AB (FRA:N9X) has a 3-Year ROIIC % of -46.95 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on New Nordic Healthbrands AB and its competitors. According to the industry distribution chart, New Nordic Healthbrands AB ranks #1586 out of 1833 companies in the Consumer Packaged Goods industry, placing it in the top 86.5%.
Is New Nordic Healthbrands AB's 3-Year ROIIC % too high?
New Nordic Healthbrands AB's current 3-Year ROIIC % is -46.95. Based on the distribution chart, New Nordic Healthbrands AB ranks #1586 out of 1833 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, New Nordic Healthbrands AB has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does New Nordic Healthbrands AB's 3-Year ROIIC % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, New Nordic Healthbrands AB ranks #1586 out of 1833 companies for 3-Year ROIIC %. This places New Nordic Healthbrands AB in the lower half of its industry. The industry median 3-Year ROIIC % is 2.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Consumer Packaged Goods company?
The median 3-Year ROIIC % among Consumer Packaged Goods companies is 2.72, based on 1,833 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on New Nordic Healthbrands AB and its competitors. For the Consumer Packaged Goods industry, the median 3-Year ROIIC % is 2.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. New Nordic Healthbrands AB's current 3-Year ROIIC % is -46.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Nordic Healthbrands AB stock overvalued right now?
New Nordic Healthbrands AB (FRA:N9X) has a current 3-Year ROIIC % of -46.95. The stock's GF Value™ is €1.73, compared to a current price of €1.26 — trading 27.2% below its estimated fair value. The current 3-Year ROIIC % is -46.95. New Nordic Healthbrands AB's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For New Nordic Healthbrands AB (FRA:N9X), the current 3-Year ROIIC % is -46.95 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is New Nordic Healthbrands AB (FRA:N9X) Overvalued in 2026?
Based on GuruFocus' analysis, New Nordic Healthbrands AB stock appears to be undervalued.
The current stock price of €1.26 is trading 27.2% below its estimated GF Value™ of €1.73.
Key valuation signals for FRA:N9X:
3-Year ROIIC %: -46.95
GF Value™: €1.73 vs. price of €1.26 (27.2% below fair value)
No single metric tells the full story. See the FRA:N9X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
62GF Score
Get the complete analysis for FRA:N9X
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:N9X has been successfully added to your 
